0000899243-16-022546.txt : 20160613
0000899243-16-022546.hdr.sgml : 20160613
20160613083849
ACCESSION NUMBER: 0000899243-16-022546
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160601
FILED AS OF DATE: 20160613
DATE AS OF CHANGE: 20160613
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
BUSINESS PHONE: 972-865-2206
MAIL ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: STAPLETON CRAIG R
CENTRAL INDEX KEY: 0001207106
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 161709938
MAIL ADDRESS:
STREET 1: 135 E. PUTNAM AVE
CITY: GREENWICH
STATE: CT
ZIP: 06830
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stapleton Pharma LLC
CENTRAL INDEX KEY: 0001676901
STATE OF INCORPORATION: CT
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 161709939
BUSINESS ADDRESS:
STREET 1: 55 OLD FIELD POINT ROAD
STREET 2: 2ND FLOOR
CITY: GREENWICH
STATE: CT
ZIP: 06830
BUSINESS PHONE: (203) 622-1382
MAIL ADDRESS:
STREET 1: 55 OLD FIELD POINT ROAD
STREET 2: 2ND FLOOR
CITY: GREENWICH
STATE: CT
ZIP: 06830
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2016-06-01
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001676901
Stapleton Pharma LLC
55 OLD FIELD POINT ROAD, 2ND FLOOR
GREENWICH
CT
06830
0
0
1
0
0001207106
STAPLETON CRAIG R
55 OLD FIELD POINT ROAD, 2ND FLOOR
GREENWICH
CT
06830
0
0
1
0
Class A common stock
452864
I
See Footnote
Class B common stock
Class A common stock
365800
I
See Footnote
Held of record by Stapleton Pharma LLC, a Connecticut limited liability company. Craig R. Stapleton is the sole managing member of Stapleton Pharma LLC and may be deemed to beneficially own all of the securities held of record by Stapleton Pharma LLC. However, Mr. Stapleton disclaims beneficial ownership of the issuer's securities held of record by Stapleton Pharma LLC except to the extent of his pecuniary interest therein.
The Class B common stock is convertible into Class A common stock on a one-for-one basis (a) at the holder's election at any time after the date that is six months following the date of the closing of the initial public offering of the company's Class A common stock, (b) at the holder's election prior to that time subject to certain conditions, or (c) at the option of the company's board of directors, in its sole discretion, at any time or multiple times from time to time on or before the closing of the initial public offering. The conversion right of the Class B common stock has no expiration date.
/s/ Craig R. Stapleton, Sole Managing Member of Stapleton Pharma LLC
2016-06-13
/s/ Craig R. Stapleton
2016-06-13